Nagla Abdel Karim։ Discussions on Lung Cancer Screening and Treatment Approaches at MaTOS Lung 2026
Nagla Abdel Karim/LinkedIn

Nagla Abdel Karim։ Discussions on Lung Cancer Screening and Treatment Approaches at MaTOS Lung 2026

Nagla Abdel Karim, Associate Professor of Medicine of George Washington University, shared on X:

“Starting the wonderful MaTOS Lung 2026 with a powerful talk from Dr. Donnington on challenges in establishing a successful Lung Cancer Screening!

Thank you Luis E. Raez, Edgardo S. Santos, Karen Reckamp, Christine Lovly for such great program!

Nagla Abdel Karim

It was such a great pleasure debating with Wade Iams on the topic of choosing our first line maintenance therapy in SCLC.

Nagla Abdel Karim

One unique case presentation by Estela Rodriguez for a patient with NTRK fusion, Low PDL1 with challenging AEs to targeted therapies.

Nagla Abdel Karim

Great updates Delvys Rodriguez Abreu on KRAS G12D, G12V, Pan-KRAS and Selective KRAS inhibitors.

Nagla Abdel Karim

David Gandara giving an outstanding presentation summarizing the need of additional biomarkers in the world of IO as we await the results of Insigna.

Nagla Abdel Karim

You can also read:

Nabil Chehab։ Preventive Lung Cancer Screening Through AstraZeneca’s LungHealth, Unified Program.

Turning Lung Cancer Screening into a National Program at European Cancer Summit 2026 – Lung Cancer Europe.

National Study Confirms Impact of NHS Lung Cancer Screening Programme – The Royal Marsden.